Veritable’s Merck MRK Stock Holding History

Veritable’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150,041	Closed	-$17.3M	–	513
2023 Q2	$17.3M	Sell	150,041 -1,480	-1%	-$168K	0.27%	40
2023 Q1	$16.1M	Sell	151,521 -371	-0.2%	-$40.1K	0.26%	42
2022 Q4	$16.9M	Sell	151,892 -559	-0.4%	-$57.1K	0.29%	42
2022 Q3	$13.1M	Sell	152,451 -10,206	-6%	-$911K	0.25%	47
2022 Q2	$14.8M	Sell	162,657 -2,593	-2%	-$230K	0.27%	45
2022 Q1	$13.6M	Buy	165,250 +1,182	+0.7%	+$93.2K	0.21%	62
2021 Q4	$12.6M	Buy	164,068 +5,886	+4%	+$469K	0.19%	66
2021 Q3	$11.9M	Buy	158,182 +15,205	+11%	+$1.16M	0.19%	65
2021 Q2	$11.1M	Buy	142,977 +1,285	+0.9%	+$95.6K	0.18%	66
2021 Q1	$10.4M	Sell	141,692 -2,451	-2%	-$181K	0.18%	67
2020 Q4	$11.3M	Sell	144,143 -8,276	-5%	-$633K	0.21%	62
2020 Q3	$12.1M	Buy	152,419 +125	+0.1%	+$9.79K	0.24%	52
2020 Q2	$11.2M	Sell	152,294 -7,145	-4%	-$538K	0.24%	57
2020 Q1	$11.7M	Sell	159,439 -8,069	-5%	-$634K	0.28%	45
2019 Q4	$14.5M	Sell	167,508 -2,226	-1%	-$183K	0.27%	48
2019 Q3	$13.6M	Sell	169,734 -756	-0.4%	-$60.6K	0.27%	48
2019 Q2	$13.6M	Sell	170,490 -4,801	-3%	-$368K	0.27%	48
2019 Q1	$13.9M	Buy	175,291 +1,809	+1%	+$135K	0.28%	46
2018 Q4	$12.6M	Buy	173,482 +1,702	+1%	+$120K	0.29%	44
2018 Q3	$11.6M	Sell	171,780 -879	-0.5%	-$56K	0.23%	60
2018 Q2	$10M	Sell	172,659 -697	-0.4%	-$39.3K	0.21%	66
2018 Q1	$9.01M	Buy	173,356 +3,531	+2%	+$191K	0.19%	73
2017 Q4	$9.12M	Sell	169,825 -36,150	-18%	-$2M	0.18%	76
2017 Q3	$12.6M	Buy	205,975 +3,094	+2%	+$188K	0.26%	51
2017 Q2	$12.4M	Buy	202,881 +522	+0.3%	+$31.8K	0.28%	47
2017 Q1	$12.3M	Buy	202,359 +3,335	+2%	+$202K	0.29%	47
2016 Q4	$11.2M	Buy	199,024 +11,994	+6%	+$702K	0.27%	51
2016 Q3	$11.1M	Buy	187,030 +8,695	+5%	+$508K	0.28%	54
2016 Q2	$9.8M	Sell	178,335 -7,081	-4%	-$377K	0.25%	57
2016 Q1	$9.36M	Buy	185,416 +11,327	+7%	+$555K	0.24%	58
2015 Q4	$8.77M	Buy	174,089 +10,545	+6%	+$532K	0.24%	63
2015 Q3	$7.71M	Buy	163,544 +856	+0.5%	+$45.5K	0.23%	67
2015 Q2	$8.84M	Sell	162,688 -34,848	-18%	-$1.95M	0.24%	66
2015 Q1	$10.8M	Buy	197,536 +4,068	+2%	+$230K	0.23%	71
2014 Q4	$10.5M	Sell	193,468 -382	-0.2%	-$21.3K	0.22%	81
2014 Q3	$11M	Buy	193,850 +666	+0.3%	+$37.4K	0.23%	70
2014 Q2	$10.7M	Buy	193,184 +1,039	+0.5%	+$56.7K	0.22%	74
2014 Q1	$10.4M	Sell	192,145 -2,664	-1%	-$138K	0.23%	74
2013 Q4	$9.3M	Buy	194,809 +7,821	+4%	+$358K	0.2%	80
2013 Q3	$8.49M	Sell	186,988 -5,332	-3%	-$243K	0.2%	85
2013 Q2	$8.52M	Buy	+192,320	New	+$8.59M	0.21%	80

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Veritable's MRK Position: Q3 2023 in Review

Veritable sold out of Merck (MRK) in Q3 2023, closing a stake of 150,041 shares — an estimated $17.3M sold.

Veritable first reported a position in MRK in Q2 2013 and held it in 41 quarters. The position peaked at $17.3M in Q2 2023. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

Veritable reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
Veritable sold 150,041 Merck shares in Q3 2023, an estimated $17.3M.
Veritable first reported a position in Merck in Q2 2013 and held it in 41 quarters.
Veritable's Merck position peaked at $17.3M in Q2 2023.
3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Veritable's 13F filing for Q3 2023.